GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » EV-to-EBIT

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) EV-to-EBIT : 27.94 (As of May. 22, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value is ₺19,294 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₺691 Mil. Therefore, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT for today is 27.94.

The historical rank and industry rank for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT or its related term are showing as below:

IST:GENIL' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.77   Med: 15.66   Max: 37.64
Current: 27.94

During the past 6 years, the highest EV-to-EBIT of Gen Ilac Veglik Urunlerinayi ve Ticaret AS was 37.64. The lowest was 6.77. And the median was 15.66.

IST:GENIL's EV-to-EBIT is ranked worse than
70.51% of 668 companies
in the Drug Manufacturers industry
Industry Median: 17.955 vs IST:GENIL: 27.94

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value for the quarter that ended in Dec. 2023 was ₺14,659 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₺691 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.71%.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS EV-to-EBIT Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS EV-to-EBIT Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - 9.77 26.90 27.05

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.90 26.13 21.08 28.63 27.05

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT falls into.



Gen Ilac Veglik Urunlerinayi ve Ticaret AS EV-to-EBIT Calculation

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19293.558/690.513
=27.94

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Enterprise Value is ₺19,294 Mil.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺691 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=690.513/14658.967
=4.71 %

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Enterprise Value for the quarter that ended in Dec. 2023 was ₺14,659 Mil.
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺691 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines